Covid-19

• As Covid-19 continues to evolve rapidly, so does the research environment, therefore, if you have any questions, please contact reb@bccancer.bc.ca directly for advice
  
• Information is also provided through PHSA and BC Cancer Communications - please ensure you regularly check for announcements 
  
• In addition, UBC is also regularly providing updates - see:  https://ethics.research.ubc.ca/ and https://research.ubc.ca/
  

Newsletters

• BC Cancer Research Ethics Newsletter_Vol.7_Jan2023.pdf
  
• BC Cancer Research Ethics Newsletter_Vol.6_Sept 2022.pdf
  
• BC Cancer Research Ethics Newsletter_Vol.5_March 2022.pdf
  
• BC Cancer Research Ethics Newsletter.October 2021.pdf
  
• BC Cancer Research Ethics Newsletter.September 2020.pdf
  
• BC Cancer Research Ethics Newsletter_Volume2 Oct2019.pdf
  
• BC Cancer REB Newsletter_Volume1 May2019.pdf
  

UBC 

• https://ethics.research.ubc.ca/

Canadian policies & references 

• Tri-Council Policy Statement (TCPS2) Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans (TCPS2) 
• http://www.hc-sc.gc.ca
  
• ICH-GCP (E6) International Committee on Harmonization-Good Clinical Practice Guidelines (ICH-GCP E6: Guidance for Industry)
  
• ICH-GCP (E8) International Committee on Harmonization-Good Clinical Practice Guidelines (ICH-GCP E8: General Considerations for Clinical Trials)

US policies & references

• FDA http://www.fda.gov/
  
• US: Code of Federal Regulations, Part 46 Protection of Human Subjects (45 CFR 46) http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm
  
• Dept. of Health & Human Services (OHRP - Office of Human Research Protections) http://www.hhs.gov/ohrp/
• HIPAA (Health Insurance Portability and Accountability Act)http://www.hhs.gov/ocr/hipaa/